HealthTech Archives - Blogs & Articles

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

July 15, 2021 MarketsandMarkets Conferences

July 12th, 2021- Genome sequencing is providing physicians with more data about the causes of cancer and changing the way some forms of the disease are treated. Continued advancements in sequencing technologies have fuelled the development of new sequencing applications. MarketsandMarkets is proud to announce the first edition of Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23rd & 24th of September 2021. A 2-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology…

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26, 2021 MarketsandMarkets Conferences

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

February 10, 2021 MarketsandMarkets Conferences

Nicola is the POCT coordinator at the Royal United Hospitals Bath Foundation Trust and have been for just over 2 years now. She has been a senior biomedical scientist in biochemistry in the manual section again for around 2 years before this and a specialist BMS since 2003. Her most recent education was the certificate in expert practice in POCT awarded by the IBMS in 2021. She has always had a great passion for POCT, and she enjoys her job despite the many challenges. She believes that POCT is the…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Jyoti Chandok from Concordia University, Canada speaks about ‘Factors leading to the increase in demand POCT tech and challenges in upholding Quality Standards.’

January 14, 2021 MarketsandMarkets Conferences

Jyoti Chandok is a seasoned professional who has been working in the healthcare sector for over 19 years. She has fulfilled several roles specializing in patient care including phlebotomy, blood analysis for hematology, immunology, genetics, and specialized method development for HIV drug-level testing using mass spectrometry. Currently, Jyoti is an Assistant Chief Medical Technologist of Point-of-Care at the McGill University Health Center (MUHC) in Montreal, Quebec, Canada. She holds a B.Sc. in Cell and Molecular Biology from Concordia University and is an active member of both the Ordre professionnel des…

FDA approves Artificial Intelligence Software for Identifying Brain Bleeds

January 19, 2019January 19, 2019 cncadmin

According to a recent report, Food and Drug Administration (FDA) has given approval for the software developed by MaxQ AI. The software is an Artificial Intelligence-based solution to diagnose and determine non-contrast CT examination images which is known as brain bleeds. Accipio Ix Intracranial Hemorrhage (ICH) of MaxQ AI uses the artificial intelligence technology platform to analyze head CT images automatically. Aidoc says that it is first of its kind in-depth learning solution to benefit radiologists in workflow group. Without affecting the workflow of the physician, this Healthcare AI technology…